Summary
- Current Price
- As of today, MDGL price is $499.86, down -0.27% on
- Current Price All-Time High
- MDGL price is currently -18.72% below its historical high of $615.00 set on
- Market Cap
- MDGL current market cap is $12B, up +83.72% over the past 365 days
- PE Ratio
- MDGL PE ratio is unknown
- Revenue
- MDGL current annual revenue is $958.40M, up +432.05% year-over-year
- Next Earnings
- The next earnings release for MDGL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Madrigal Pharmaceuticals, Inc. |
| Ticker | NASDAQ: MDGL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | madrigalpharma.com |
| Employees | 528 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $499.86 | |
| Price, 1D Change | -0.27% | |
| Market Cap | $12B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.53 | |
| Revenue | $958M | |
| Revenue, 1Y Change | +432.05% | |
| EPS | -$12.85 | |
| EPS, 1Y Change | +41.33% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:35 | |
| Next Split | N/A | N/A |
| Last Ticker Change | SNTA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$12.85 | |
| EPS Estimate | N/A | -$6.52 |
| EPS Est. Change | N/A | +49.24% |
| Revenue | $958.40M | |
| Revenue Estimate | N/A | $1.50B |
| Revenue Est. Change | N/A | +56.04% |
| Current Price | $499.86 | |
| Price Target | - | $649.50 |
| Price Tgt. Change | - | +29.94% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$23.47 | -$21.90 | +6.69% | |
| -$11.43 | -$12.85 | -12.39% | |
| -$6.52 | N/A | +49.24% | |
| $12.38 | N/A | +196.34% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $174.49M | $180.13M | +3.23% | |
| $949.73M | $958.40M | +0.91% | |
| $1.50B | N/A | +56.04% | |
| $2.21B | N/A | +130.19% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +76.80% | |
| Price, 3Y | +104.79% | |
| Market Cap, 1Y | +83.72% | |
| Market Cap, 3Y | +158.24% | |
| Revenue, 1Y | +432.05% | |
| Revenue, 3Y | +100.00% | |
| EPS, 1Y | +41.33% | |
| EPS, 3Y | +25.44% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $499.86 | |
| SMA 200 | $493.04 | |
| SMA 50 | $510.07 | |
| EMA 200 | $472.78 | |
| EMA 50 | $499.36 | |
| MACD | -$5.47 | |
| Beta | 0.53 | |
| ATR | $19.94 | |
| 14-Day RSI | 51.31 | |
| 10-Day Volatility | 34.18% | |
| 1-Year Volatility | 46.08% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $958.40M | |
| EPS | -$12.85 | |
| Gross Profit | $900.75M | |
| Gross Margin | 93.98% | |
| Operating Income | -$300.10M | |
| Operating Margin | -31.31% | |
| Net Income | -$288.28M | |
| Net Margin | -30.08% | |
| EBITDA | -$298.59M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.58 | |
| 4.01 | ||
| 3.77 | ||
| - | ||
| 2 | ||
| 9.07 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| 10.18 | ||
| 21.21 | ||
| -35.43 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $602.69M | |
| $988.65M | ||
| $1.26B | ||
| $1.25B | ||
| $656.90M | ||
| $310.29M | ||
| Total Debt | $347.63M | |
| $1.02M | ||
| $48.88M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $1.25B | ||
| $1.20B | ||
| $57.65M | ||
| $0.00 | ||
| $1.51M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$189.55M | ||
| $32.32M | ||
| $255.98M | ||
| Capex | $3.47M | |
| -$193.02M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| B of A Securities | → | |
| Truist Securities | → | |
| Evercore ISI Group | → | |
| Canaccord Genuity | → | |
| HC Wainwright & Co. | → | |
| B of A Securities | → | |
| Barclays | ||
| Citizens | → | |
| Piper Sandler | → | |
| B. Riley Securities | → |
Analyst sentiment
Institutional ownership
Screeners with MDGL
FAQ
What is the ticker symbol for Madrigal Pharmaceuticals, Inc.?
The ticker symbol for Madrigal Pharmaceuticals, Inc. is NASDAQ:MDGL
Does Madrigal Pharmaceuticals, Inc. pay dividends?
No, Madrigal Pharmaceuticals, Inc. does not pay dividends
What sector is Madrigal Pharmaceuticals, Inc. in?
Madrigal Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Madrigal Pharmaceuticals, Inc. in?
Madrigal Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Madrigal Pharmaceuticals, Inc. based in?
Madrigal Pharmaceuticals, Inc. is headquartered in United States
When did Madrigal Pharmaceuticals, Inc. go public?
Madrigal Pharmaceuticals, Inc. initial public offering (IPO) was on February 6, 2007
Is Madrigal Pharmaceuticals, Inc. in the S&P 500?
No, Madrigal Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Madrigal Pharmaceuticals, Inc. in the NASDAQ 100?
No, Madrigal Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Madrigal Pharmaceuticals, Inc. in the Dow Jones?
No, Madrigal Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Madrigal Pharmaceuticals, Inc. last earnings report?
Madrigal Pharmaceuticals, Inc.'s most recent earnings report was on May 6, 2026
When does Madrigal Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Madrigal Pharmaceuticals, Inc. is August 5, 2026
Data Sources & References
- MDGL Official Website www.madrigalpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828026009514/0001628280-26-009514-index.htm
- MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
- MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl